Simone Perazzolo is an Italian-British pharmacokineticist and software developer known for his work on physiologically-based and compartmental modeling of long-acting injectable drugs for HIV and other infectious diseases, and for maintaining the SAAM II kinetic modeling software.[1][2]
Simone Perazzolo | |
|---|---|
| Born | Verona, Italy |
| Known for | • Development of SAAM II software • Modeling of long-acting injectable antiretrovirals |
| Awards | Journal of Pharmaceutical Sciences Outstanding Scientist Award (2022, 2024) |
| Scientific career | |
| Fields | Pharmacokinetics, Physiologically-based pharmacokinetic modeling, Compartmental modeling |
| Institutions | University of Washington Nanomath LLC |
Perazzolo is affiliated with the Department of Pharmaceutics at the University of Washington in Seattle and is the founder and director of Nanomath LLC, which has distributed and further developed SAAM II since 2022.[3]
Awards
editReferences
edit- ^ a b Perazzolo, Simone (February 2023). "Outstanding Scientist Award 2022". Journal of Pharmaceutical Sciences. 112 (2): 357. doi:10.1016/j.xphs.2022.11.019.
- ^ a b Perazzolo, Simone (November 2024). "Outstanding Scientist Award 2024". Journal of Pharmaceutical Sciences. 114 (2): 641. doi:10.1016/j.xphs.2024.11.010.
- ^ Perazzolo, Simone (August 2024). "SAAM II: A general mathematical modeling rapid prototyping environment". CPT: Pharmacometrics & Systems Pharmacology. 13 (8): 1088–1102. doi:10.1002/psp4.13181. PMC 11247119. PMID 38863172.
